Catatonia is a rare manifestation of benzodiazepine withdrawal in elderly patients who have used it for a long time. We present a case of lorazepam withdrawal catatonia and highlight issues in diagnosis and management.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.ajp.2013.05.008 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Silexan in anxiety, depression, and related disorders: pharmacological background and clinical data.
Eur Arch Psychiatry Clin Neurosci
October 2024
Neurobiology Laboratory for Brain Aging and Mental Health, Psychiatric University Clinics Basel, Basel, Switzerland.
We present a narrative review of clinical trials investigating the anxiolytic and antidepressant effects of silexan, an active substance derived from lavender oil and summarize nonclinical findings from pharmacological studies supporting its therapeutic use. Six studies investigated the efficacy of the lavender oil in patients with subthreshold and generalized anxiety disorders as well as in mixed anxiety and depressive disorder (MADD). Furthermore, we present data indicating that silexan may influence sleep quality as well as anxiety or depressive disorders in individuals with post-COVID-19.
View Article and Find Full Text PDFArticle Synopsis
- A multidisciplinary team, including nurses, psychiatrists, and pharmacists, was formed to address concerns about the management of alcohol withdrawal symptoms in hospitalized patients, aiming to improve care and outcomes.
- The project used the Plan-Do-Study-Act framework to revise the medication order set, replacing lorazepam with diazepam and enhancing staff education through innovative methods like a simulation escape room.
- Post-implementation, there were no adverse patient events reported, nursing staff reported increased confidence, and all involved parties found the revised order set clear and effective, highlighting the importance of collaboration and ongoing evaluation in clinical practice.
A Case of Phenibut Withdrawal Management and Detoxification Using Baclofen in the Outpatient Setting.
Case Rep Psychiatry
July 2024
Anne Burnett Marion School of Medicine Texas Christian University, Fort Worth, TX, USA.
Phenibut, a GABA receptor agonist, has surged in popularity due to its nootropic and anxiolytic effects. Despite not being FDA approved, it is accessible online due to its marketing as a dietary supplement, leading to unregulated distribution. Increasing reports have highlighted the risks of addiction and severe withdrawal symptoms associated with phenibut use.
View Article and Find Full Text PDFEffectiveness of Gabapentin as a Benzodiazepine-Sparing Agent in Alcohol Withdrawal Syndrome.
Medicina (Kaunas)
June 2024
Department of Internal Medicine, Oregon Health and Science University, Portland, OR 97239, USA.
Gabapentin has shown promise as a potential agent for the treatment of alcohol withdrawal syndrome. We aimed to evaluate the effectiveness of gabapentin as a benzodiazepine-sparing agent in patients undergoing alcohol withdrawal treatment in all the hospitals of a large tertiary healthcare system. Medical records of patients admitted to the hospital for alcohol withdrawal management between 1 January 2020 and 31 August 2022 were reviewed.
View Article and Find Full Text PDFImpact of an alcohol withdrawal screening and treatment protocol for hospitalized patients.
J Subst Use Addict Treat
September 2024
Cooper Medical School of Rowan University, United States of America; Cooper University Healthcare Center for Healing, United States of America. Electronic address:
Article Synopsis
- Alcohol Withdrawal Syndrome (AWS) poses serious risks for individuals with alcohol use disorder, making early detection essential in hospital settings, which led to the implementation of universal AUD screening using the PAWSS scale.
- A 6-year retrospective study compared patient outcomes before and after the introduction of a treatment protocol for AWS and involved 181 patients pre-protocol and 265 post-protocol.
- While the protocol did not significantly reduce hospital length of stay, it did lead to a notable decrease in the total benzodiazepine dose given and lower rates of delirium tremens among patients.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!